ArticleInternational journal of health policy and management2020
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Article in International journal of health policy and management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases.Applied health economics and health policy · 2026Review
- The RELIANT checklist: a novel approach to revealing implicit factors in HTA deliberations.Health policy OPEN · 2026Article
- National HTA system in Canada: From system analysis and understanding to system strengthening.PLOS global public health · 2026Article
- Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual framework.International journal for equity in health · 2025Review
- The global landscape of country-level health technology assessment processes: A survey among 104 countries.Health policy OPEN · 2025Article
- Understanding healthcare demand and supply through causal loop diagrams and system archetypes: policy implications for kidney replacement therapy in Thailand.BMC medicine · 2025Article
- Standards for the conduct and reporting of health technology assessments: Ghana reference case of HTA and economic evaluations.International journal of technology assessment in health care · 2025Article
- An integrated framework to guide evidence-informed public health policymaking.Journal of public health policy · 2025Review
- Unleashing the potential: the imperative of political support for health technology assessment in Iran.Health economics review · 2024Article
- A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.Health research policy and systems · 2024Article
- Assessing medical devices: a qualitative study from the validate perspective.International journal of technology assessment in health care · 2024Article
- The development of a roadmap for Health Technology Assessment implementation in Moldova.F1000Research · 2024Article
- Evidence-Informed Oral Health Policy Making: Opportunities and Challenges.Journal of dental research · 2023Review
- Deliberative processes in health technology assessment of medicines: the case of Spain.International journal of technology assessment in health care · 2023Review
- Healthcare priority-setting criteria and social values in Iran: an investigation of local evidence.International journal of technology assessment in health care · 2023Review
- The role of Iran's context for the development of health technology assessment: challenges and solutions.Health economics review · 2023Article
- Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations.International journal of technology assessment in health care · 2023Article
- International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023).International journal of health policy and management · 2023Article
- The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan.International journal of environmental research and public health · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence-informed deliberative processes (EDPs) were recently introduced to guide health technology assessment (HTA) agencies to improve their processes towards more legitimate decision-making. The EDP framework provides guidance that covers the HTA process, ie, contextual factors, installation of an appraisal committee, selecting health technologies and criteria, assessment, appraisal, and communication and appeal. The aims of this study were to identify the level of use of EDPs by HTA agencies, identify their needs for guidance, and to learn about best practices.
methodsA questionnaire for an online survey was developed based on the EDP framework, consisting of elements that reflect each part of the framework. The survey was sent to members of the International Network of Agencies for Health Technology Assessment (INAHTA). Two weeks following the invitation, a reminder was sent. The data collection took place between September-December 2018.
resultsContact persons from 27 member agencies filled out the survey (response rate: 54%), of which 25 completed all questions. We found that contextual factors to support HTA development and the critical elements regarding conducting and reporting on HTA are overall in place. Respondents indicated that guidance was needed for specific elements related to selecting technologies and criteria, appraisal, and communication and appeal. With regard to best practices, the Canadian Agency for Drugs and Technologies and the National Institute for Health and Care Excellence (NICE, UK) were most often mentioned.
conclusionThis is the first survey among HTA agencies regarding the use of EDPs and provides useful information for further developing a practical guide for HTA agencies around the globe. The results could support HTA agencies in improving their processes towards more legitimate decision-making, as they could serve as a baseline measurement for future monitoring and evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.